A randomized trial of radium-223 dichloride and cabozantinib in patients with advanced renal cell carcinoma (RCC) with bone metastases (RADICAL / Alliance A031801)
- Citation:
- J Clin Oncol vol 39 (no. 15_suppl) TPS4593
- Meeting Instance:
- ASCO 2021
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10CA180820 (ECOG-ACRIN)
- Corr. Author:
- Authors:
- Rana R. McKay Heather Jacene Pamela Atherton Gabriela Perez-Burbano Archana Ajmera Shiva Baghaie Janet Koball Tyler Zemla Ron Chen Atish Choudhury Joshua M. Lang Suzanne Cole Tareq Al Baghdadi Young Kwok Himisha Beltran Daniel George Michael Morris Toni K. Choueiri
- Networks:
- CA249, LAPS-MA036, LAPS-NC010, LAPS-NY016, LAPS-TX011, LAPS-WI020, MD015
- Study
- Alliance-A031801
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: